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Background: Gastrointestinal food allergy (GIFA) occurs in 2 to 4 % of children, the majority of whom are infants
(<1 year of age). Although endoscopy is considered the gold standard for diagnosing GIFA, it is invasive and
requires general anaesthesia. Therefore, we aimed to investigate whether in infants with GIFA, gastrointestinal
symptoms predict histological findings in order to help optimise the care pathway for such patients.
Methods: All infants <1 year of age over a 20 year period who underwent an endoscopic procedure gastroscopy
or colonoscopy for GIFA were evaluated for the study. Symptoms at presentation were reviewed and compared
with mucosal biopsy histological findings, which were initially broadly classified for study purposes as “Normal” or
“Abnormal” (defined as the presence of any mucosal inflammation by the reporting pathologist at the time of biopsy).
Results: Of a total of 1319 cases, 544 fitted the inclusion criteria. 62 % of mucosal biopsy series in this group were
reported as abnormal. Infants presenting with diarrhoea, rectal (PR) bleeding, irritability and urticaria in any combination
had a probability >85 % (OR > 5.67) of having abnormal histological findings compared to those without. Those with
isolated PR bleeding or diarrhoea were associated with 74 % and 68 % probability (OR: 2.85 and 2.13) of an abnormal
biopsy, respectively. Conversely, children presenting with faltering growth or reflux/vomiting showed any abnormal
mucosal histology in only 50.8 % and 45.3 % (OR: 1.04 and 0.82) respectively.
Conclusions: Food allergy may occur in very young children and is difficult to diagnose. Since endoscopy in infants
has significant risks, stratification of decision-making may be aided by symptoms. At least one mucosal biopsy
demonstrated an abnormal finding in around half of cases in this selected population. Infants presenting with
diarrhoea, PR bleeding, urticaria and irritability are most likely to demonstrate abnormal histological findings.
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Gastrointestinal food allergy (GIFA) is increasing in
prevalence and usually affects very young children [1].
Approximately 2-4 % of children between the ages of 0-
3 years are diagnosed with food allergy [2, 3] and up to
60 % of these children display gastrointestinal symptoms* Correspondence: neil.shah@gosh.nhs.uk
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rhoea. Other children may present with symptoms affect-
ing skin, such as eczema, catarrhal problems or even
anaphylaxis. Clinically, symptoms are often very pro-
nounced and warrant investigations to eliminate other
diagnoses before food allergy is considered [2, 4, 5]. Nor-
mally, the mucosal barrier in the gastrointestinal (GI) tract
develops an “oral tolerance” to food antigens ingested [6].
However, in children with food allergy, this mechanism is
believed to fail, resulting in allergic sensitisation and elicit-
ation of allergy-type responses [6, 7]. This reaction, whichcle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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be classified as immunoglobulin E (IgE)-mediated allergy,
non-IgE mediated allergy or mixed IgE and non-IgE al-
lergy [8]. Gastrointestinal food allergies (GIFA) are gener-
ally considered as non-IgE mediated, but eosinophilic
dominant gastrointestinal disorders may be mixed IgE and
non-IgE allergies. The most common age of presentation
of non-IgE mediated allergies affecting the gut is in chil-
dren under the age of one year, with cow’s milk, soy pro-
tein, hens’ egg and wheat being the most frequent causative
foods [2, 4, 5, 9, 10].
The immunopathology of non-IgE mediated GIFA is
still not fully understood, which makes diagnosis and
management difficult, often requiring an elimination diet
followed by food challenge [8, 11]. Endoscopy and bi-
opsy has become increasingly important, with some con-
sidering endoscopic biopsy as the gold standard since it
is relatively objective and may provide information regard-
ing possible mechanisms. [4, 7] For example, in eosino-
philic oesophagitis, the histological appearance defines the
diagnosis [12]. However, endoscopy for very young chil-
dren is often limited to specialised centres and involves
general anaesthesia, requiring administration by paediatric
anaesthetists, and procedural risks such as intestinal per-
foration [13, 14]. There are no studies investigating gastro-
intestinal symptoms in relation to histological features in
infant GIFA [15]. Hence, the aim of this study was to in-
vestigate whether specific symptoms are associated with
abnormal histological findings in endoscopic biopsiesFig. 1 Frequencies of abnormal biopsy findings for single symptoms and cobtained from children with GIFA in order to optimise
care pathway decision making.
Methods
Routinely collected data was reviewed from children
under the age of one-year referred to a tertiary paediatric
gastroenterology centre during the study period (June
1987 to August 2007), who had undergone endoscopic
biopsy. Jejunal biopsies performed by the now historical
procedure of Crosby capsule (common in the early years
of our study) were excluded, and we also excluded chil-
dren biopsied for other indications unrelated to GIFA.
For all cases clinical symptoms were assessed in relation
to histopathological findings based on contemporaneous
biopsy reports. A single researcher extracted data ac-
cording to predefined objective criteria.
All biopsies were reported by specialist paediatric histo-
pathologists from the same tertiary centre. For the pur-
poses of this study, histopathological findings were coded
as either “Normal” or “Abnormal” (presence of any signifi-
cant abnormal finding at any biopsy site including acute
or chronic inflammation, with or without increased muco-
sal eosinophil density [16], or other pathologies such as
partial villous atrophy or Helicobacter pylori see Fig. 1).
Chronic inflammation with predominantly excess mucosal
eosinophil density was considered most suggestive of food
allergy in this cohort of young children [12, 17, 18].
Data were analysed using IBM SPSS Statistics for Win-
dows, Version 22 (Armonk, NY). Continuous variablesombinations of symptoms common to two regression models
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categorical variables as frequencies and percentages.
Mann-Whitney U test and chi-square test were used to
examine the differences between groups.
For all symptoms in isolation (in cases when the patient
presented with only one symptom) Positive Predictive
Values (PPV) of abnormal biopsy findings were calculated.
Multiple logistic regression was used to investigate the re-
lationship between biopsy findings and symptoms with ad-
justment for potential confounders of age and gender.
Based on logistic regression models, probabilities of ab-
normal biopsy findings were calculated for combinations
of symptoms using the median age. Goodness of fit of lo-
gistic regression models was based on Hosmer-Lemeshow
test. All tests were two-tailed and significance level was set
to 0.05. The study was approved by the local Research
Ethics Committee (Bloomsbury REC). All data was retro-
spective and identified by study number only and individ-
ual patient consent was not required for data inclusion.
The study conformed to the Helsinki declaration regard-
ing research performance.
Results
Of 1319 infants undergoing endoscopic biopsies, 318
were excluded due to insufficient clinical information,
265 due to being Crosby capsule biopsies and 60 due to
specific non GIFA indications (congenital diarrhoea,
autoimmune enteropathy, graft-versus-host disease, tuft-
ing enteropathy and disaccharidase deficiency), leaving
676 patients who met the inclusion criteria. Some pa-
tients had multiple endoscopies and repeat biopsies, 122
in total, which were also excluded and only the initial
presentation biopsy included. 554 endoscopic biopsy
series were therefore included. Fifty-one per cent (285/
554) were male, median age 7 months (IQR = 0.2-12
months). Overall, 62 % (344/554) had abnormal mucosal
biopsy findings. The median age of those with abnormal
biopsy was significantly lower than those with normal
findings (median 6.6 months versus median 7.5 months,
P < 0.001).
The most common presenting symptoms as indica-
tions for endoscopy were reflux/vomiting (40 %), falter-
ing growth (37 %), diarrhoea (35 %) and rectal (PR)
bleeding (12 %). 309 (56 %) patients presented with one
symptom, 190 (34 %) with two, 49 (9 %) with three and
six patients (1 %) with four symptoms. Positive predict-
ive values (PPV) for symptoms based on the patients
who presented with one symptom (n = 309) are shown
in Table 1.
Diarrhoea was associated with a significantly greater
frequency of abnormal histological findings than falter-
ing growth (70.8 % vs. 50.8 %, p = 0.018) or reflux
(70.8 % vs. 45.3 %, p = 0.001). PR bleeding was associated
with a significantly greater rate of abnormal histologicalfindings than faltering growth (74.2 % vs. 50.8 %, p =
0.031) or reflux (74.2 % vs. 45.3 %, p = 0.004). There
were no significant differences between the frequency of
abnormal biopsies between those presenting with diar-
rhoea and PR Bleeding, (p = 0.728) or those presenting
with reflux and faltering growth, (p = 0.484).
Multiple logistic regression models were used to assess
the frequency of any abnormal biopsy findings with
combinations of symptoms (Hosmer-Lemeshow p =
0.373), as well as the probability of increased mucosal
eosinophil density (Hosmer-Lemeshow p = 0.413), ad-
justed for differences in age and gender. Diarrhoea (p <
0.001), PR bleeding (p < 0.01), irritability (p < 0.05) and
urticaria (p < 0.05) were significantly associated with
both abnormal biopsy and excess eosinophils (Table 2).
The site, Oesophagus, stomach, duodenum or colon, of
the abnormal findings are shown in Table 3. Faltering
growth, constipation and abdominal distension were
also predictors of finding eosinophils in a biopsy (p <
0.05, p < 0.01, p < 0.05 respectively; Table 2). Age was
an important confounding factor as we found a higher
probability of an abnormal biopsy in younger children.
Among others, reflux/vomiting was a poor predictor;
therefore it was excluded from the models. Similarly,
gender was not a significant confounding factor.
Specific symptom combinations were more likely to
have biopsies with excess eosinophils present. For ex-
ample, children who presented with a combination of
diarrhoea, PR bleeding and urticaria had an 88 % fre-
quency of excess eosinophils.
Discussion
This is the first large study to examine whether specific
symptoms at presentation in very young children are as-
sociated with abnormal endoscopic biopsy findings in
children being assessed for GIFA. The findings demon-
strate that younger infants are more likely to have abnor-
mal mucosal histological findings, and those presenting
with specific combinations of symptoms are associated
with high frequency of abnormal mucosal biopsy findings,
including increased mucosal eosinophil density. In the
current patient population, first presentation of GI symp-
toms occurred at around five months of age. However, it
is likely that this represents a highly selected group re-
ferred to a specialist centre who are likely to have been ex-
periencing more severe symptoms and hence were
evaluated earlier in life than the general population and
were all deemed to have symptoms of sufficient severity to
warrant endoscopic examination. The risks of undergoing
a general anaesthetic procedure and associated potential
complications involved in performing endoscopy in very
young infants as well as the impact on families are import-
ant considerations when deciding on whether to perform
an endoscopy [13, 14, 19].
Table 1 Positive Predictive Values (PPV) of abnormal mucosal biopsies in infants being assessed for GIFA based on a single presenting
gastrointestinal symptom based on 309/554 patients who presented with one symptom only
Number Percent Isolated increased mucosal eosinophil density PPV Any abnormal biopsy PPV
n n
Reflux/vomiting 117 37.9 % 19 16.2 % 53 45.3 %
Diarrhoea 72 23.3 % 30 41.7 % 51 70.8 %
Faltering growth 61 19.7 % 19 31.1 % 31 50.8 %
PR Bleeding 31 10.0 % 16 51.6 % 23 74.2 %
Haematemesis 7 2.3 % 1 14.3 % 4 57.1 %
Constipation 6 1.9 % 3 50.0 % 3 50.0 %
Feeding difficulties 4 1.3 % 0 0.0 % 0 0.0 %
Irritability 4 1.3 % 1 25.0 % 2 50.0 %
Anaemia 2 0.6 % 0 0.0 % 0 0.0 %
Hypoalbuminaemia 2 0.6 % 0 0.0 % 2 100.0 %
Abdominal distension 2 0.6 % 1 50.0 % 1 50.0 %
Recurrent Abdominal pain 1 0.3 % 0 0.0 % 1 100.0 %
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vomiting, PR bleeding and faltering growth. Of these, if
isolated, infants presenting with diarrhoea or PR bleed-
ing, had an approximate 70 % probability of a histologi-
cally abnormal biopsy. However, infants who presented
with combinations of diarrhoea, PR bleeding, irritability
and urticaria were both more likely to have abnormal bi-
opsy findings and also more likely to demonstrate in-
creased mucosal eosinophil density. For example, almost
90 % of those presenting with diarrhoea and irritability
had an abnormal biopsy. There were few patients who
presented with irritability in isolation (1.3 %). However, it
is possible that parents and clinicians underreport this
symptom especially in the presence of other more com-
mon and recognisable symptoms. [20, 21] The frequency
of an abnormal biopsy was lower for infants presenting
with reflux/vomiting (45 %) and faltering growth (51 %).
Food allergic diagnoses are classified according to the
site and severity of inflammation, which influences theTable 2 Multiple logistic regression models for association with abn
Regression model for excess eosinophils in b
Variables in the model B p-value
Constant −0.96 0.001
Age (months) −0.07 0.033
Urticaria 1.50 0.007
Irritability 1.69 <0.001
PR Bleeding 1.12 < 0.001
Diarrhoea 0.79 < 0.001
Constipation 1.42 0.002
Abdominal Distension 1.24 0.045
Faltering growth 0.49 0.016presenting symptoms. With gastrointestinal mucosal dis-
ease that is identified by endoscopic biopsy there is a
close spatial relationship of inflammatory mediators
known to be released by mucosal inflammatory cells and
enteric nerves [2]. The exact mechanisms of the mani-
festations of gastrointestinal symptoms are slowly being
unravelled with the concept of paracrine immune inter-
action on the enteric nervous system, being known as a
neuro-immune interaction [22, 23] leading to the dis-
turbed motility and symptoms seen in GIFA such as re-
flux, diarrhoea or constipation. Much workstill needs to
be done to fully explain how these symptoms develop
and respond to dietary or anti-inflammatory measures.
Limitations of the study are related to the retrospect-
ive nature of data collected over a long time period with
possible associated variation in the clinical suspicion of
GIFA and management of such infants by endoscopic
examination and biopsy. In GIFA, despite adherence to
the diagnosis only being made by clinicians in out unitormal mucosal biopsies in infants being assessed for GIFA











Table 3 Symptoms related to the site of abnormal findings in cases with only a single site affected
Oesophagus (n = 61) Percent Stomach (n = 16) Percent Duodenum (n = 50) Percent Colon (n = 44) Percent
Reflux/Vomiting 44 72 % 5 31 % 19 38 % 15 34 %
FTT 18 30 % 5 31 % 26 52 % 18 41 %
Diarrhoea 5 8 % 6 38 % 19 38 % 18 41 %
PR Bleeding 3 5 % 0 0 % 5 10 % 10 23 %
Constipation 0 0 % 2 13 % 3 6 % 8 18 %
Anaemia 0 0 % 0 0 % 0 0 % 2 5 %
Feed Diff 2 3 % 2 13 % 3 6 % 2 5 %
Mouth Ulcers 0 0 % 0 0 % 0 0 % 0 0 %
Rash 1 2 % 0 0 % 3 6 % 2 5 %
Irritability 2 3 % 1 6 % 4 8 % 5 11 %
Haematemesis 6 10 % 3 19 % 1 2 % 0 0 %
Hypoalbuminaemia 0 0 % 1 6 % 2 4 % 1 2 %
Abd. Distension 1 2 % 0 0 % 1 2 % 5 11 %
RAP 1 2 % 0 0 % 0 0 % 3 7 %
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egg, soya and wheat usually) with clinical improvement
and subsequent reappearance of symptoms on rechal-
lenge, the diagnosis remains subjective. The symptoms
can be delayed and is unblended and subject to paren-
tal reporting. Furthermore, even with such a large data-
set, for the purposes of this study we have classified
mucosal biopsy findings broadly into normal versus ab-
normal, (with the only subcategory being those with
apparently isolated increased mucosal eosinophil dens-
ity at any site since this has been suggested as the most
characteristic feature of GIFA) [12, 24]. More detailed
sub-analysis of the relationship between other specific
histological findings and their combinations with symp-
toms is not possible in this dataset and much larger
numbers of cases, all of whom undergo multiple biop-
sies from small and large intestinal sites, would be re-
quired, but is unlikely to be available.
The clinical decision regarding whether an infant re-
quires endoscopic examination and biopsy for diagnosis
of food allergy can be difficult, since the procedure in
this age group requires general anaesthesia with associ-
ated risks. The current data demonstrates that specific
symptom patterns at presentation are associated with
varying yield of abnormal mucosal histological findings, in
particular, infants who experience diarrhoea, PR bleeding,
irritability and urticaria having a high frequency of abnor-
mal biopsies. This information may aid the decision mak-
ing process for young children presenting with probable
food allergy.
Conclusions
Gastrointestinal food allergy (GIFA), may present with a
wide variety of symptoms in the first year of life andspecific symptom patterns at presentation are associated
with varying yield of abnormal mucosal histological find-
ings at endoscopic biopsy. Infants who experience diar-
rhoea, PR bleeding, irritability and urticaria have a high
frequency of abnormal gastrointestinal mucosal biopsies,
including prominent mucosal eosinophils.
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